| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVLN | NOVELION THERAPEUTICS INC. | Harshbarger Benjamin | See Remarks | May 09, 2019 | Option Exercise | $1.22 | 212 | 259 | 3,683 | May 13, 2019, 04:05 PM | |
| NVLN | NOVELION THERAPEUTICS INC. | Harshbarger Benjamin | General Counsel | May 09, 2018 | Option Exercise | $4.26 | 322 | 1,372 | 4,143 | Nov 05, 2018, 06:36 PM | |
| NVLN | NOVELION THERAPEUTICS INC. | Harshbarger Benjamin | General Counsel | May 15, 2018 | Option Exercise | $4.15 | 150 | 623 | 3,993 | Nov 05, 2018, 06:36 PM | |
| NVLN | NOVELION THERAPEUTICS INC. | Harshbarger Benjamin | General Counsel | Sep 17, 2018 | Option Exercise | $3.94 | 98 | 386 | 3,895 | Nov 05, 2018, 06:36 PM | |
| NVLN | NOVELION THERAPEUTICS INC. | Harshbarger Benjamin | General Counsel | Apr 01, 2018 | Option Exercise | $3.50 | 52 | 182 | 4,465 | Apr 03, 2018, 12:00 AM | |
| NVLN | NOVELION THERAPEUTICS INC. | Harshbarger Benjamin | General Counsel | Sep 17, 2017 | Option Exercise | $7.08 | 109 | 772 | 1,673 | Sep 19, 2017, 04:46 PM | |
| NVLN | NOVELION THERAPEUTICS INC. | Harshbarger Benjamin | General Counsel | May 15, 2017 | Option Exercise | $8.97 | 232 | 2,081 | 1,445 | May 17, 2017, 04:02 PM | |
| NVLN | NOVELION THERAPEUTICS INC. | Harshbarger Benjamin | General Counsel | May 09, 2017 | Option Exercise | $9.42 | 234 | 2,204 | 960 | May 11, 2017, 04:01 PM | |
| NVLN | NOVELION THERAPEUTICS INC. | Harshbarger Benjamin | General Counsel | Apr 01, 2017 | Option Exercise | $10.74 | 57 | 612 | 470 | Apr 04, 2017, 04:02 PM | |
| AEGR | Aegerion Pharmaceuticals, Inc. | Harshbarger Benjamin | General Counsel | Sep 17, 2016 | Option Exercise | $1.78 | 532 | 947 | 1,704 | Sep 20, 2016, 04:03 PM | |
| AEGR | Aegerion Pharmaceuticals, Inc. | Harshbarger Benjamin | General Counsel | Apr 01, 2016 | Option Exercise | $3.55 | 273 | 969 | 594 | Sep 20, 2016, 04:03 PM |
Menu